The role of serum MicroRNA in the diagnosis and treatment evaluation of neonatal pneumonia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027343

Enrollment

Unknown

Registered

2019-11-09

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal pneumonia

Interventions

Gold Standard:1. lower respiratory tract and/or systemic symptoms

2. chest X-ray positive radiograph or computed tomography (CT) suggested pneumonia.

Index test:MicroRNA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newborn (age = 35 weeks; Weight 2.0 kg or more.

Exclusion criteria

Exclusion criteria: use antibiotics before delivery; APGAR score <7 at 5 min; Accompanied by congenital malformations.

Design outcomes

Primary

Measure	Time frame
microRNA;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactWang Yongfen

The Second Affiliated Hospital of Fujian Medical University

13600786986@qq.com+86 13600786986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026